Identity
- Trade Name
- LIAISON® Control HSV-2 IgG FDA UDI
- Generic Name
- Herpes simplex virus 2 (HSV2) immunoglobulin G (IgG) antibody IVD, control FDA UDI
- Model / Reference
- 310621 FDA UDI
Identifiers
- Primary DI / UDI-DI
- 08056771600118 FDA UDI
- GMDN Term
- Herpes simplex virus 2 (HSV2) immunoglobulin G (IgG) antibody IVD, control FDA UDI
Classification
- Commercial Distribution
- In Commercial Distribution FDA UDI
Clinical & Handling
Sterile
No
FDA UDI
Single Use
No
FDA UDI
Implantable
No
FDA UDI
Contains Latex
No
FDA UDI
Prescription Use
No
FDA UDI
Over-the-Counter
No
FDA UDI
Convenience Kit
Yes
FDA UDI
Combination Product
No
FDA UDI
HCT/P
No
FDA UDI
Premarket Exempt
No
FDA UDI
Lot / Batch Number
Yes
FDA UDI
Serial Number
No
FDA UDI
Expiration Date
Yes
FDA UDI
Manufacturing Date
No
FDA UDI
Category: Herpes simplex virus 2 (HSV2) immunoglobulin G (IgG) antibody IVD, control
LIAISON® Control HSV-2 IgG by Diasorin Inc. — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS
Similar devices
Also classified as Herpes simplex virus 2 (HSV2) immunoglobulin G (IgG) antibody IVD, control.
- Atellica IM Herpes-2 IgG Quality Control — Siemens Healthcare Diagnostics · Class I
- HSV-2 ELISA IgG Low Positive Control — DiaSorin Molecular LLC · Class II
- ADVIA Centaur Herpes-2 IgG Quality Control — Siemens Healthcare Diagnostics · Class I
- HSV-2 ELISA IgG High Positive Control — DiaSorin Molecular LLC · Class II
Authorization Coverage (1 country)
Regulatory Authorizations
United States Pending data
FDA UDI
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| FDA UDI | United States | FDA UDI | Registered in GUDID | N/A | Pending data |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Diasorin Inc.
Sources (1)
- FDA UDI 2efd48eb-9171-4bc6-b7fc-817d5419f12e 33 fields · synced Jun 8, 2026